← Leaderboards
Jeffrey K Yao
University Of Pittsburgh At Pittsburgh
$1,572,557
Attributed
$1,783,276
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $403.9K · FY2009–15$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,783,276 · 3
VA$0 · 1
By mechanism
R01$978,887 · 1
R21$804,389 · 2
I01$0 · 1
Top collaborators
- Robert B Gibbs2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Christian E Schafmeister$3,262,605
- Alexander Star$1,857,523
- Lori A Birder$16,985,823
- Karoly Mirnics$12,881,071
- Alan F Sved$12,398,418
Others in their field
Top investigators on “Phospholipids”
- Eugene W. St Clair · Duke University$24,182,181
- Valerian E Kagan · Wistar Institute$23,533,341
- Stanley J Opella · Wistar Institute$22,975,332
- Joel S. Bennett · University Of Pennsylvania$17,733,101
- George M. Carman · Rutgers The St Univ Of Nj New Brunswick$16,801,187
- Daniel E Kahne · Harvard University$16,303,151
Research focus
PhospholipidsSchizophreniaLeadResponsePathway InteractionsArachidonatePublic Health RelevanceMembraneEicosanoidsMental DisordersArachidonic AcidsAffectEquilibriumBiochemicalEarly DiagnosisDisabilityLightCost EffectiveAntipsychotic AgentsDiagnosisCell MembraneCutaneousBlood FlowFlowmeters
Grant awards (12)
Evaluation of a Physiologic Marker for Schizophrenia in First-Episode Psychosis$171,570
R21 · FY2015 · MH · contact PI
Evaluation of a Physiologic Marker for Schizophrenia in First-Episode Psychosis$211,381
R21 · FY2014 · MH · contact PI
Impact of Estrogens and Menopause on Interacting Monoamine Neurotransmitters in t$192,500
R21 · FY2014 · AG
Impact of Estrogens and Menopause on Interacting Monoamine Neurotransmitters in t$228,938
R21 · FY2013 · AG
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia$0
I01 · FY2013 · VA · contact PI
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia$0
I01 · FY2012 · VA · contact PI
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia$0
I01 · FY2011 · VA · contact PI
Phospholipid-Arachidonate-Eicosanoid Signaling in Schizophrenia$0
I01 · FY2009 · VA · contact PI
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIA$233,357
R01 · FY2003 · MH
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIA$237,332
R01 · FY2002 · MH
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIA$262,638
R01 · FY2001 · MH
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIA$245,560
R01 · FY2000 · MH